MICHAEL J. YANG

CIK 1702283 · EVP and CCO · last filed 2026-01-20

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$1.08M

Companies

4

Total Filings

28

Lifetime Open-Market Net

-$7.15M

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
IONS Director 7,940 $73.28 $581.8K $0 8 2026-01-20
PCRX Director 13,393 $22.99 $307.9K $25.8K 4 2025-06-13
ACAD EVP and CCO 9,179 $21.09 $193.6K -$7.18M 13 2021-01-08
AKCEA THERAPEUTICS, INC. (AKCA) Delisted Director $0 3 2020-10-13

Recent Filings · Page 3 of 3

28 filings
Form 4 transactions across all companies, newest first.
Filed Symbol Action Net Shares Net $ Link
2019-12-11 ACAD Mixed -$212.1K EDGAR
2019-10-17 ACAD Mixed +1,623 -$34.8K EDGAR
2019-09-23 AKCEA THERAPEUTICS, INC. (AKCA) Delisted Grant (A) $0 EDGAR
2019-05-01 ACAD Grant (A) $0 EDGAR
2018-10-24 ACAD Grant (A) $0 EDGAR
2018-04-20 ACAD Grant (A) $0 EDGAR
2017-09-08 ACAD Grant (A) $0 EDGAR
2017-03-31 ACAD Grant (A) $0 EDGAR
Showing 2128 of 28
Page 3 of 3
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.